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INTRODUCTION
Bladder cancer accounts for 7% of all cancers in male and 2% of all cancers in female.  
9.Urinary  cytology  has  an  increasingly  prominent  role  in  the  multidisciplinary  diagnostic 
approach to  bladder  cancer.  It  is  used as  a  valuable  adjunct  to  cystoscopy and biopsy  for 
diagnosis and follow up of patients with bladder cance.
Urine cytology remains gold standard for bladder cancer screening.  It is the test against 
which  all  others  are  compared  when  evaluating  potential  bladder  tumor  markers.   It  has 
excellent specificity with few false positive cases
Cytological  examination of voided urine is a  non-invasive screening test  for bladder 
tumors, which can be carried out in remote areas of the country. By cytology one can even 
classify type and grade malignancy.  
In 1945 Papaniculoau and Marshall recommended cytological examination of urinary 
sediment for diagnosis and follow up of patients with urological malignancies.   
The  prognostic  value  of  conventional  cytology  to  monitor  patients  with  superficial 
bladder carcinoma is well established. While cystoscopy and biopsy are optimum for diagnosis 
of visible disease, the entire bladder mucosa can be sampled by cytology, enabling detection of 
occult urothelial abnormalities.   
Traditionally  cytological  examinations  have  been  used  to  detect  in  situ  and  early 
invasive bladder cancer in high-risk population and in conjunction with cystoscopy and biopsy 
to diagnose new or recurrent bladder tumor.  Cytology also has been used to identify persistent 
tumor after transurethral resection. 
Cystoscopy remains the standard for the diagnosis and surveillance of bladder tumors, 
allowing the lesions to be mapped and sampled.   However,  cystoscopy cannot explore the 
whole bladder urothelium, and cannot diagnose all carcinoma in situ cases or lesions of upper 
urinary tract.  Thus, it must be combined with urinary cytology, particularly in search for tumor 
cells from high-grade lesions, wherever their location in the urinary tract.
Urine cytology can detect bladder tumor before it can be detected cystoscopically. Urine 
cytology is still indispensable in the management of patients with transitional cell carcinoma. It 
remains as a gold standard for bladder cancer screening.
                                                                         
AIMS
1. To  correlate  urine  cytology  with  histopathology  of  the  bladder  Transitional  Cell 
Carcinoma.
2. To  study  the  role  of  urinary  cytology  in  the  diagnosis  of  bladder  Transitional  Cell 
Carcinoma.
3. To find out the correlation between the grading by urine cytology and histopathology.
4. To analyze the reason for false positive and false negative cytological        results
REVIEW OF LITERATURE
Cancer bladder was first noted in man in aniline industry in 1895.  Cancer bladder is  
three times more common in men than in women and twice as common among whites as 
among blacks. The average patient is 65 to 70 years old and most patients are older than 50  
years of age. 
The bladder  temporarily  stores concentrated toxic products  of renal excretion and is 
vulnerable to environmental carcinogens. Most important risk factors for the development of 
transitional  cell  carcinoma  are  aniline  dyes  containing  arylamines,  e.g.benzidine,  beeta 
naphthylamine.  High-risk  occupations  include  chemical,  dye,  textile,  rubber,  and  plastic 
workers as well  as painters and hairdressers.  Cigarette smoking is a risk factor for bladder 
cancer. Certain drugs [eg.chemotherapeutic agents, phenacetin and opiates] are associated with 
the development of bladder cancer.
Schistosoma  haematobium  infection  is  a  risk  factor  for  sqamous  cell  carcinoma. 
Previous exposure of the bladder to radiation increases the risk of urothelial carcinoma. Many 
genetic  alterations  are  observed  in  urothelial  cell  carcinoma,  comman  are  chromosome  9 
monosomy or deletions of 9p and 9q, deletions of 17p, 13q, 11p and 14q. The pathway, which is 
initiated by deletions of tumor suppressor genes on 9p and 9q leads to superficial  papillary 
tumors, a few of which may then acquire P53 mutations and progress to invasion. The second 
pathway,  which  is  initiated  by  P53 mutations  leads  to  carcinoma  in  situ  and  with  loss  of 
chromosome 9, progresses to invasion.
The urocarcinogens, by injuring the coding units of the urothelial cells,  render them 
defective, leading to hyperplasia and neoplasia, with the action of  promoters. 
TUMORS OF THE URINARY BLADDER17 
Benign epithelial tumors
Typical papilloma 
Inverted papilloma
Villous adenoma
Mucinous cystadenoma of the urachus
Squamous papilloma
Malignant epithelial tumors
Transitional cell carcinoma 
Papillary
(1) superficial
(2)  muscle  - invasive
Non-papillary
(1) Transitional cell carcinoma in-situ
(2) Invasive transitional cell carcinoma
 Squamous cell carcinoma.
Adenocarcinoma
Carcinomas of more than one histologic type
Mesenchymal tumors
Benign
Malignant 
     (1) Leiomyosarcoma
     (2) Rhabdomyosarcoma
     (3) Others
Mixed tumors
Adenofibromas and adenosarcomas
Carcinosarcoma
Hematopoietic neoplasms
Lymphoma
Leukemia
Plasmacytoma
Miscellaneous primary tumors
Paraganglioma
Carcinoid
Malignant melanoma
Dermoid cyst
Yolk sac tumor
Metastatic tumors
URINE CYTOLOGY 
Tumor cells in the urine were identified first by Sanders in 1864 and Dickson in 1869. In 
1892,  Ferguson  suggested  that  microscopic  examination  of  the  urine  sediment,  except  for 
cystoscopy  was  the  best  method  for  diagnosing  tumors  of  the  bladder.  Rovising  in  1895 
reported malignant cells in the urine sediment of 3 out of 7 patients with kidney tumors.  
However,  in  1928  Zemansky  correlated  urinary  findings  with  subsequent  tissue 
examination in 46 cases of suspected tumors and called the urine unfit  for cytologic study. 
Interest in cytologic diagnosis waned until the studies by Papanicolaou and Marshell in 1945, 
supplemented by Papanicolaou a year later demonstrated the usefulness of smear technique in 
diagnosing cancers of  urinary organs.  Because of  the  normal  desquamation from epithelial 
surfaces, which increases in the presence of neoplasia, they considered the urine sediment most 
suitable for the identification of cells with malignant characteristics32.
           Since Papanicolaou and Marshall demonstrated in 1945 that a bladder tumor undergoes  
exfoliation, which renders possible its recognition by detection of abnormal cells in the urine, 
cytology has become an important adjuvant for the diagnosis and follow up of patients with 
cancer.  In 1964 Umiker reviewed the literature on the value of urinary cytology and found 
positive results ranging from 26.1 to 100% with an average of 71.6%. In 1972, Harris and 
associates used the principle of gastric washing for cytology, which was reported previously by 
Villarded, and performed bladder irrigation, his yield improved by 30% over urinary cytology. 
In 1970, Esposti and associates emphasized the importance of the pathological grading of the 
tumor in influencing the cytological results43.
          Tumors of the urinary tract are relatively inaccessible to direct biopsy and the tumors are 
often multifocal.  Since the entire mucosal surface is bathed in urine, in theory urine is the 
perfect specimen to examine for evidence of tumor in the urinary tract.
Urinary cytology is useful in the detection of 
1. Urothelial carcinoma in its preclinical phase. 
2. Carcinoma in situ. .  
3. Follow up of patients after treatment to detect any residual or recurrent tumors.
    Cytologic examination of the sediment of voided urine is the only noninvasive method of  
detection, diagnosis and follow up of tumors of the bladder and other anatomic components of 
the lower urinary tract. Urine cytology is a cost effective method. 
    Urine cytology remains gold standard for bladder cancer screening.  It is the test against  
which  all  others  are  compared  when  evaluating  potential  bladder  tumor  markers.   It  has 
excellent specificity with few false positive cases.  It detects high grade malignant cells even 
before a cystoscopically distinguishable gross lesion is present11. Urine cytology is capable of 
detecting malignant non-exophytic tumor types that ultrasound cannot detect34. 
     The study conducted by M. N. EL-Bolkainy30 1980 showed that the cytology is highly 
effective in the primary diagnosis of high grade transitional cell carcinoma with a positive rate 
of 93-94.7%.
     The study conducted by Leopold G. Koss et al24 1985 also showed the cytology of voided 
urine is highly reliable in the diagnosis of high grade tumors with a sensitivity of 94.2%.  In  
primary flat carcinoma in situ the sensitivity was 100%.     
      Patients with low-grade non-invasive tumors can be followed up cytologically. Patients  
with  negative  cytological  findings  have  a  very  low  risk  of  recurrence  while  high-grade 
cytological abnormalities predict an aggressive tumor course.
      Niels Harving et al33 1988 in their study, concluded that urinary cytology is also better 
indicator of the presence of concomitant urothelial atypia than preselected mucosal biopsies.
      Post operative (radical operation) examination of urine for malignant cells should be made 
out to monitor the development of new tumors in the kidney  ureter or occasionally in the 
intestine itself. 
     Clinical history is imperative for the elimination of misdiagnosis. Pertinent information 
includes the method of specimen collection, the presence of calculi and past therapies. To use 
urine cytology most effectively it is important first to understand its advantages and limitations.
Advantages of voided urine cytology.
1. Simple, can be easily collected.
2. Repeated if necessary, with little or no inconvenience for the patient. 
3. Inexpensive. 
4. Non invasive.
5. Can be done even in remote areas of the country.
6. Detects high grade malignancy before cystoscopy can detect.
7. Samples of urine may contain representative cells from the entire urinary tract. So that the 
entire system can be surveyed.
Disadvantages of voided urine cytology           
1. Low cellularity.
2. Contamination from female genital tract.
3. May  contain  degenerated  cells  or  reactive  transitional  cells  which  may  give  false 
positive results.
4. Not localizes the tumor.
     An important diagnostic principle is  that  the higher the grade of the tumor,  the more 
accurate  the  diagnosis.    There  are  several  reasons  for  diagnostic  inaccuracy.  Urine  is  an 
inhospitable environment for cells. So degenerative changes that make diagnosis difficult are 
common. 
    False positive results can occur due to mistaking of  atypical cellular changes as malignant. 
Common  causes  of  cellular  atypia  are  cystitis,  senile  prostate,  calculi,  chemotherapy  and 
radiotherapy effects, and  virus infection. 
     False positive diagnosis of bladder cancer may lead to radical therapy, so a positive urine 
cytologic  diagnosis  should  always  be  confirmed  histologically  before  definitive  therapy  is 
instituted12,37.  Most patients with false positive cytological findings may develop a tumor in 
subsequent years and therefore need repeated examinations of urine for malignant cells.
     False negative diagnosis may be of more clinical consequence. Cytologic diagnosis of 
papilloma and well  differentiated transitional  cell  carcinoma can be difficult  or  impossible 
because the cells are nearly normal appearing. False negative diagnosis may be due to low 
cellularity, poor preservation or obscuring of malignant cells by inflammatory cells.
Suboptimal Specimen
According to Sheldon Bastacky et al41 1999, urinary specimen is considered suboptimal, if the 
specimen had one or more of the following deficiencies 
1. Less than 15 intermediate or basal urothelial cells.
2. Obscuring of malignant cells by red blood cells or inflammatory cells. 
3. Poor cellular preservation. .
      Following newer diagnostic techniques have been studied to increase diagnostic efficacy. 
 Flow cytometry16,39.
 Image analysis1.
 Immunology e.g.-blood group isoantigens  and monoclonal  antibodies to  a variety  of 
tumor associated antigens3,15,16,40,46.
 Immune histochemical analysis of p53 over expression21.
 Nuclear matrix protein 22 (NMP22) assay3,15,40,46.
 The aura Tek FDP assay (Fibrin/Fibrinogen Degradation products)3,40.
 Measuring telomerase activity3,40.
 Detecting hyaluronic acid/ Hyaluronidase levels11.
BASIC SPECIMEN
 There are three basic types of exfoliated urinary tract specimens: 
          (1) Voided urine 
          (2) Catheterized urine, and 
          (3) Brushing/washing specimens. 
     "Clean catch" voided urine is recommended for screening purposes. However, in cases in 
which there is a high clinical suspicion for bladder malignancy, bladder washing may be the 
method of choice. 
      Specimens should be processed immediately or refrigerated and processed as soon as 
possible.  If  a  delay  is  anticipated,  immediate  fixation with 50% ethanol  may preserve the 
specimen for several days16,30,51. 
     A solution of 25% ethanol [equal volume of 50% ethanol and urine.] is widely used. This 
percentage is recommended in order to lessen the shrinkage and hardening effects of more 
concentrated solution52.
     All  urine  cytology  specimens  are  sufficiently  dilute  as  to  require  some form of  cell 
concentration.  Initially, cytologic findings were assesed on smears made from the sediment of 
centrifuged  specimen.   Subsequently  developed  methods  include  thin  membrane  filtration, 
cytocentrifugation and most recently mono layer technique11.
     Urinary samples can be processed by several techniques including direct smears, membrane 
filters and cytocentrifugation. All have certain advantages and  disadvantages. In general direct 
smears are easiest to prepare but suffer from high cell loss and suboptimal display of cellular  
details. Membrane filters produce the best cytologic details, but are difficult to prepare51.
     Cytyc thinprep liquid based cytology and cytocentrifugation are appropriate methods for 
cytology  based  molecular  studies  but  cytocentrifugation  remains  the  quality  standard  for 
current treatment of urinary samples because of its lower cost9.
     Papanicolaou stain is usually preferred.  Since fine nuclear detail is often crucial to proper 
diagnosis. 
 Voided Urine 
     Normal  voided  urine  usually  contains  only  a  few  cells.   Normal  urine  contains  
approximately 10 cells/ml51. Voided urine also contains significant amount of skin and vaginal 
contamination particularly in female. Increased cellularity may be seen with instrumentation, 
stones or neoplasms.
    The transitional cells in urine have a some what trapezoidal (truncated pyramid or trapezium) 
shape.  The  transitional  cells  in  a  voided  urine  specimen  are  generally  relatively  uniform. 
However, the cells can vary from parabasal to relatively large. The nuclei are round to oval 
with smooth nuclear membranes. The chromatin is delicate or condensed. Small nucleoli may 
be seen. There is usually a moderate amount of cytoplasm37. 
     Urine cytology should be performed on freshly voided urine. A mid morning sample is the 
most useful. Fractionated cytology did not improve the diagnostic accuracy of urinary cytology 
and that any part of voided stream is adequate for cytological purposes22.  Samples should be 
collected in a clean container and sent to the laboratory immediately. If the specimen has to be 
transported or kept overnight alcohol should be added to preserve the cells 
     Cell loss from slides can be minimized by using adhesive fluids. The paraffin blocks of 
sediments are useful in identification of papillary tumor fragments.  
     The optimum number of voided urine samples to submit is three. Of the neoplasms that can  
be diagnosed with voided urine cytology, about 80% will be on the first specimen, 15% on the 
second, and the rest on the third24. 
         Degenerative  changes,  are  common  in  voided  urine  specimens.  Factors  causing 
degeneration include high acidity and variable osmolality of the urine.     Degeneration of 
urothelial cells begin prior to exfoliation and continuous while the cells are in contact with 
urine prior to and after voiding.
      Specimen should not be submitted from first morning voiding, 24 hours collection or 
drainage bags as prolonged exposure of urothelial cells to urine causes degenerative changes. 
Catheterized urine
     Simple  catheterization  increases  the  cellularity  over  voided urine  specimens,  and the 
specimen may be somewhat better preserved. However, it makes the diagnosis of low-grade 
lesions more difficult  because pseudo papillary clusters  may be present,  and lesions in the 
urethra may be missed.
Bladder wash
     Bladder wash specimens are diagnostically superior to voided urine specimens.    The 
specimens are better preserved, more cellular and there is less contamination of the background 
than voided urine specimen. It is important that the urologist submit both the saline wash and 
the  urine  present  in  the  bladder  at  cystoscopy ("cysto urine").  Cysto urine  does  pick up a 
significant number of additional cases of cancer. 
     A freshly voided urine specimen should be submitted to detect  lesions in the urethra. 
Although  bladder  washing  is  superior  to  voided  urine  in  diagnosis,  it  is  inconvenient, 
uncomfortable, relatively expensive, and has a risk of infection.
Advantages and Disadvantages of Voided Urine and Bladder Washing Specimen. 
11,16,32,43,45,47,48,49,52
 CELLS
 
Urothelium 
is  composed 
of 
superficial 
layer of large cells which cover several layers of uniform smaller cells like an umbrella, hence 
named umbrella  cells.  Superficial  cells  have  abundant  cytoplasm and  typical  concave  and 
convex surfaces with multiple nucleoli. They have a rigid surface membrane which does not 
round up in fluid environment. So that these elements are readily identified in urinary samples. 
They can produce and secrete small amount of mucin. Reactive superficial cell may look like a 
high  grade  neoplastic  cell  but  truly  malignant  cells  rarely  if  ever  differentiate  towards 
superficial cells. So these cells should not be misinterpreted as neoplastic cells and no cell with 
a N; C ratio (Nuclear; Cytoplasmic) of 1; 2 or less should be considered malignant.
Advantages         Disadvantages      
Voided urine 
  Easy to obtain specimen Degeneration 
 Good sensitivity for high- grade tumor Few cells, particularly in lowgrade tumor 
  Sample entire tract Contamination, especially from 
female genital tract 
Bladder washing 
      Excellent preservation Inconvenient, uncomfortable, expensive
     High sensitivity, including 
low-grade tumors 
Possible risk of infection, spread of  tumor
     Almost no contamination                    Limited sample[ie, urethra, upper 
urinary tract not sampled]
Normal voided urine sediment smear showing subsuperficial transitional cells. Pap 
stain 400X.
Normal urine sediment smear showing superficial cells and sub superficial small 
uniform cells. Papstain 400X.
    
 Sub superficial transitional cells lie beneath the superficial cell  layer. They are smaller, 
uniform, normally filled with glycogen which washes out during processing leaving a cleared 
cytoplasm, surrounding an ovoid nucleus. These cells are usually arranged in 3 to 4 cell thick 
layers but probably not exceeding 6. They are inactive, replicate every 200 to 500 days. These  
cells tend to cluster in a urinary specimen. Instrumentation can produce papillary aggregates in 
urine  but  these  aggregates  are  having  smooth  borders  and  cells  are  uniform.   Papillary 
configuration per se is an unreliable feature of neoplasia. Reactive sub superficial transitional 
cells  develop  cytoplasimic  vacuolation,  nuclear  enlargement  and  nucleoli  become 
prominent.Most neoplastic cells tend to differentiate toward subsuperficial urothelial cells.It is 
these elements to which comparison of nuclear characteristics between neoplasia and  normal 
are made51.
     Cytoplasmic vacuolization and prominent nucleoli can be seen in either  reactive transitional 
cells  or  in  high  grade  transitional  cell  carcinoma,  but  their  presence  excludes  low  grade 
transitional cell carcinoma.
 
Normal urine sediment smear showing superficial cell with double nuclei Pap stain 
400X.
Degenerated Transitional Cells
     Degeneration (caused by inflammation, stones, trauma, etc) can result in bizarre transitional  
cells with darkly condensed coarse or pyknotic chromatin Although such changes can resemble 
cancer, the chromatin of these benign cells is usually smudged or degenerated. In contrast, the 
chromatin  granules  of  cancerous  cells  are  characteristically  crisp  and  well  preserved. 
Margination of the chromatin, with central clearing, is also frequent in degenerated transitional 
cells. Degenerated nuclei may further undergo karyolysis and karyorrhexis and become washed 
out or broken up. The cytoplasm may disintegrate and be merely a tag attached to the nucleus  
(comet cell) or absent together37.
Significance of Papillary Clusters.
     Instrumentation,  catheterization  or  even simple  manipulation  of  the  bladder  produces 
papillary aggregates, that mimic tissue fragments detached from low grade papillary tumors. 
      The papillae from transitional cell carcinoma tend to be disorganized and crowded, with 
irregular borders and mild nuclear atypia, while post instrumentation pseudo-papillae tend to be 
cohesive, ball-shaped, or papillary clusters with smooth borders outlined by a densely staining 
cytoplasmic collar. However, when papillary clusters are shed in  urine in low grade transitional 
cell carcinoma, they may be mistaken for artifacts induced by  instrumentation45.        
Normal urine sediment smear showing squamous cell and transitional cells. H&E stain 
400X.
Normal urine sediment smear showing squamous cell and transitional cells. H&E 
stain 400X.
     Uniform central nuclei, smooth nuclear membranes, fine even chromatin, low N/C ratios, 
cytoplasmic vacuoles, and general lack of crowding favor a benign diagnosis16. 
Squamous Cells and Squamous Metaplasia
     Squamous cells are a common finding in urine specimens. Source of squamous cells are 
contamination of urine by squamous cells from urethral meatus, female genital tract, cells from 
trigone, metaplastic squamous cells.
  Squamous  metaplasia  occurs  in  chronic  inflammation  or  irritation  (stones,  indwelling 
catheter). The metaplastic cells are usually mature, intermediate, or superficial squamous cells. 
Squamous  metaplasia  should  be  diagnosed  only  after  exclusion  of  contamination,  thus  it 
requires a catheterized specimen.
Columnar cells
     Columnar cells generally account for less than 5% of all cells in a urinary specimen.  They 
commonly appear after prostatic surgery or instrumentation25. 
Red blood cells and inflammatory cells
     Normally the urine is virtually free of inflammatory cells and RBCs. Significant numbers  
indicate  disease  or  trauma  and  when  abundant  may  obscure  the  presence  of  tumor  cells. 
Hematuria results from any disease or trauma to the Kidney and/or urinary tract and is seen 
with calculi, neoplasm, infections.
Cellular Reaction to Therapeutic Agents
1.Cyclophosphamide is alkylating agent given systemically and metabolized to active form. 
The  active  form  is  concentrated  in  urine  and  remains  in  contact  with  urothelial  cells  for 
relatively prolonged periods until voided. Cyclophosphamide causes cellular atypia that can 
closely mimic cancer. The presence of multinucleated cells with signs of nuclear degeneration 
(karyorrhexis, lysis, and nuclear vacuolization) suggests chemotherapy effect.
2.  Mitomycin  C and Thiotepa  are  topically  applied  alkylated  agents  administrated  in  their 
active form for prevention or treatment of bladder neoplasm.  The drugs remain in contact with 
urothelium for limited periods prior to voiding.  Their cytologic manifestations are confined 
almost exclusively to superficial cells, where they cause enlargement of both cytoplasm and 
nuclei resulting in characteristic but bizarre cells. Nuclei are usually not hyperchromatic but 
those that are usually have smudgy appearing chromatin. Multiple small nucleoli are common. 
The cytoplasm is degenerated, vacuolated and frayed.
3. Bacillus Calmette-Guérin [BCG] vaccine is an increasingly common therapeutic agent 
for  bladder  cancer  that  is  particularly  effective  in  treating carcinoma in  situ.   BCG 
therapy can also cause epithelial atypia, including slight nuclear  hyperchromasia with 
cytoplasmic basophilia23.  In  contrast  with cancer,  the N/C ratio is  preserved and the 
nuclear membranes are smooth. Significant nuclear pleomorphism, prominent nucleoli, 
or cytomegaly are not seen in the transitional cells.
Radiation
     Radiation can cause certain cytologic changes,  especially multinucleation, cytoplasmic 
vacuolization and nuclear pyknosis.  Bizarre nuclear abnormalities can occur51.
     It is not possible to distinguish with any degree of certainity malignant from non-malignant 
irradiated  urothelial  cells  in  urine.  History  of  previous  irradiation  should  be  given  to  the 
cytologist.If numerous bizarre cells appear long after radiation, or if there has been an interim 
period when cytologic appearances were normal, then recurrence is strongly suggested36.
BLADDER CANCER
    Transitional cell carcinoma or urothelial carcinoma accounts for 90% of all primary tumors 
of bladder.
    Most bladder cancers appear as a focal or multifocal expression of widespread abnormality 
of urothelium, progression of which leads to multicentricity in space and recurrence in time. 
 Clinical Presentation
     Eighty percent of the patients with bladder carcinoma present with gross or microscopic, 
painless  and  intermittent  hematuria.  Twenty  percent  of  patients  will  complain  of  vesical 
irritative symptoms including urinary frequency and urgency. It is important to consider CIS 
[Carcinoma In Situ.] in any patient with a history of irritative voiding symptoms. Patients with 
invasive bladder cancer may have abdominal tenderness or bladder mass or induration.
Biologic Pathways 
     Two  distinct  pathways  are  suggested  in  urothelial  neoplasia.  A lowgrade  pathway 
hypothesized  in  approximately  70% the  of  cases.   It  is  characterized  by  progression  from 
hyperplasia/dysplasia to papilloma to low grade transitional cell carcinoma. The lesions have 
bland  cytology  and  normal  blood  group  isoantigens  and  are  predominantly  diploid. 
Recurrences are frequent and multiple, but only minority of the cases (10 to 15%) progress to 
muscle invasion.
     In  the  high grade pathway most  invasive lesions  arise  without  a  history  of  papillary 
neoplasms. They progress directly from flat lesions of severe dysplasia/carcinoma in situ to 
invasive high grade transitional cell carcinoma and are associated with mortality.  Such lesions 
have pleomorphic cytology, manifest high mitotic rates, lack normal blood group isoantigens, 
and are usually aneuploid11,50.
     The flat carcinoma in situ may precede invasive carcinoma by months or years. A primary 
goal of urine cytology is to recognize these early flat lesions before they invade, as well as to 
detect the 10% of papillary lesions that are destined to invade11.
Cytologic classification of urothelial malignancy.
  The lesion acts like it looks51.
General Principles of Cytologic Diagnosis
     Higher the grade and the more extensive the tumor, greater the ability to make a cytologic 
diagnosis. Cells shed from transitional cell carcinoma in situ have a similar cytomorphology as 
high-grade invasive lesion. One cannot reliably determine whether a lesion is in situ or invasive 
cytologically.
Cellular features of urothelial neoplasia50,51
Low grade High grade
Cells
Arrangements  Papillary and loose 
clusters     
Isolated and loose clusters
Size Increased, uniform Increased, pleomorphic
Number Often numerous Variable
Cytoplasm Homogeneous Variable May have 
vacuoles
Nuclear Cytoplasmic 
ratio
Increased Increased
Low grade High grade
Nuclei 
Position Extremely eccentric Eccentric
Size Enlarged Variable
Morphology Variable within aggregates Variable
Borders Irregular Irregular
Chromatin Fine, even coarse, uneven
Nucleoli Small/Absent Variable
Differential diagnosis.
     Differential Diagnosis includes atypia due to catheterization, cystitis, stones, radiation and 
chemotherapy.
Differentiating features of reactive cell, low grade and high grade                    TCC 
High nuclear cytoplasmic ratio, irregular nuclear membrane, nonvacuolated cytoplasm 
are three key features in the diagnosis of low grade transitional cell carcinoma42.
Differentiating features of reactive cell, low grade and high grade                    TCC 20,44,50,51
Feature Reactive Low grade TCC High grade TCC
Groups Pseudopapillae Papillae, loose or crowded clusters  Loose clusters/syncitia/single
Cells Enlarged, pleomorphic variable in number.
Enlarged, relatively 
uniform, often 
numerous.
Enlarged, pleomorphic.
N/C ratio Normal/increased Increased(slight to moderate) Increased(moderate to marked)
Nucleus Central Eccentric, enlarged. Eccentric, pleomorphic
Nuclear 
membrane Smooth,thick. Slightly irregular, thin Moderate to markedly irregular.
Chromatin Fine, even Granular, even Coarse, dark, irregular
Nucleoli Often large Small to none Macronucleoli in many cells
Cytoplasm Vacuolated Homogenous Often vacuolated also squamous
Background Inflamed or clean Clean Diathesis
Dysplasia
     Dysplasia describes a flat, non-invasive premalignant lesion distinguished from reactive or 
reparative epithelium.  The cytologic diagnosis of urothelial dysplasia is a point of contention. 
The  cells  are  reported  to  have  a  lesser  degree  of  cytologic  atypia  than  transitional  cell 
carcinoma in situ but are similar in appearance to cells from low-grade papillary neoplasms. 
The chief differences are the small number of dysplastic cells present in urinary specimens, the 
aggregation of cells into small but loose clusters, a lower N/C ratio [Nuclear Cytoplasmic ratio] 
and  fine  evenly  distributed  chromatin.   In  truth  urothelial  dysplasia  cannot  reliably  be 
segregated from low-grade TCC with subjective criteria of cytology alone.
Papilloma 
Papillomas  are  well-differentiated  papillary  transitional  cell  neoplasms.  Many 
papillomas  are  composed  of  cells  with  normal  or  nearly  normal  morphologic  appearance, 
making cytologic diagnosis difficult or impossible. Others have morphologic feature of low-
grade neoplasm.  Therefore only  1/3rd  to  2/3rd of these lesions can be diagnosed cytollogically 
and the higher diagnostic yield (fewer false negatives) comes at the expense of more false-
positive diagnosis50.
         Numerous cells may be exfoliated. Loose clusters and papillary aggregates commonly 
occur,  but  must  be  differentiated  from  pseudopapillary  clusters  related  to  trauma 
instrumentation, stones, etc. True papillary fronds with fibrovascular cores are diagnostic of 
papillary neoplasia10. However, their presence is not essential for cytologic diagnosis. The cells 
and their nuclei are larger than normal deep transitional cells (but not superficial cells). The cell 
borders are often indistinct. The cytoplasm is homogeneous rather than vacuolated. The nuclei 
are eccentric and have slightly irregular membranes in the form of notches or creases. The 
chromatin is fine and evenly distributed. Nucleoli, if present, are small50,51.
Carcinoma in Situ:
A lesion in which transitional epithelium, of variable thickness, is composed of variably 
sized abnormal  cells  with significant  nuclear  and cytoplasmic abnormalities,  limited to  the 
epithelium and never crosses the basal layer.
Squamous Cell Carcinoma
          Squamous cell carcinoma can be accurately identified from cells in urine sample.  They 
are usually well differentiated and exfoliate fairly mature cells with an elongated, spindled or 
fusiform configuration. Cytoplasmic keratinization can often be distinguished.  Nuclear border 
is irregular. Nuclear deformation is common.
Adenocarcinoma
         Primary adenocarcinomas are rare in the bladder.  The adenocarcinoma cells tend to  
cluster and have poorly stained, lucent, vacuolated cytoplasm. Chromatin tends to aggregate 
along smooth nuclear borders and manifests. Nucleoli are prominent. 
Diagnostic correlation between cytologic and cystoscopic examination37.
Cytology Cystoscopy Likely diagnosis
(-) (-) No tumor.
(-) (+) Well differentiated papillary neoplasm.
(+) (-) Carcinoma in situ (or) upper tract tumor.
(+) (+) High grade, invasive TCC
       
      Transabdominal ultrasonography has also been used to complement urine cytology in the  
detection of bladder tumors.
Pitfalls in urinary cytology
 Over interpreting cells with low N/C ratio [Nuclear Cytoplasmic ratio] as Cancer cells. 
 Mistaking papillary aggregates as a reliable sign of low grade neoplasia               
 Confusing the reactive/regenerative/reparative cell associated with urinary  stones with 
neoplastic cells.
 Over interpreting samples from the upper collecting system.
 Misinterpreting cells in ileal conduits and 
 Misunderstanding the cytologic effects of drugs and X ray therapy. 
  
Morphologic features
     TCC [Transitional Cell Carcinoma] can arise any where in the bladder.
Common locations are: 
         Lateral walls 37%
         Posterior wall 18%
         Trigone 12%
          Neck 11%
          Ureteric orifices 10%
          Dome 8% and
          Anterior wall 4%
  Pattern of growth may be exophytic or endophytic or a combination of both. Exophytic tumor 
may  adopt  a  papillary  configuration  (with  central    fibrovascular  core)  or  a  solid 
appearance(nodular). 
     Exophytic tumor results in clusters of tumor cells in the lamina propria which may be under  
diagnosed as Von Brunn’s nests or cystitis glandularis or cystica.  This is referred to as the 
nested variant of transitional cell carcinoma.
     Stromal invasion by transitional cell carcinoma proceeds in two stages. Invasion of the 
lamina propria and invasion of muscle layer. Muscle invasion is of great consequence because 
of its influence on therapy and prognosis.  Care should be exercised not to misinterpret the 
inconsistent  but  sometimes  prominent  fascicles  of  muscularis  mucosa  as  belong  to  the 
muscularis propria.It is also important not to misinterpret the mature adipose tissue commonly 
present in the lamina propria or muscularis propria as perivascular soft tissue, in order to avoid 
a tumor adjacent to fat in a biopsy specimen being badly overstaged.
The cyto architectural variations that may occur in transitional cell carcinoma are 
1. Foci  of  glandular  metaplasia  are  common,  usually  in  the  form of  intra-cytoplasmic 
mucin containing vacuoles. 
2. Foci of squamous differentiation especially in high grade tumors may be seen.
3. Clear  cells  may  be  prominent  in  transitional  cell  carcinomia  and  simulate 
adenocarcinoma.
4. Micropapillary  pattern  may  occur  which  resembles  that  of  ovarian  serous  papillary 
carcinoma.
5. Rare  variant  of  TCC  is  characterized  by  a  plasmacytoid  appearance  that  mimics 
myeloma. 
Bladder Biopsy
Transurethral Resection
     Before  tumors  are  resected,  their  location,  number  and  size  should  be  noted. 
Endoscopically  visualised  characterization  with  predictive  value  for  disease  progression 
include shape (papillary versus sessile and flat), size (less than 2 cm versus greater than 5 cm)  
and the presence of associated mucosal abnormalities.
Kenneth B. Cummings et al21 suggested hot loop resection of the tumor, after adequate 
biopsy mapping of bladder mucosa. He also insisted that the resection must include sufficient 
muscle to allow adequate pathologic staging. As an adjunct to hot loop resection, a cold up 
biopsy of the tumor edge or base can provide muscle for pathologic staging while reducing 
charring  artifact  and  the  risk  of  bladder  perforation.  Video  cystoscopy,  combined  with 
continuous-flow resectoscope, will allow safe resection in almost all cases.
.Grading and Staging                 
Grading of urothelial tumors.18
WHO/ISUP  Grades  (World  Health  Organization/International  Society  of  Urological  
Pathology). Adopted as WHO system in 2004.
     Urothelial papilloma
     Urothelial neoplasm of low malignant potential
     Papillary Urothelilal Carcinoma, low grade
     Papillary Urothelial Carcinoma, high grade.
WHO Grades (1973)
     Urothelial Papilloma
     Urothelial neoplasm of low malignant potential
     Papillary Urothelial Carcinoma,   Grade 1
     Papillary Urothelial Carcinoma,   Grade 2
     Papillary Urothelial Carcinoma,   Grade 3   
Histologic  feature  used  to  classify  Urothelial  Papillary  lesions  according  to  the  scheme  
proposed by  the  WHO/ISUP [The World  Health  Organization /  International  Society  of  
Urological Pathology].19
Papilloma Papillary neoplasm of 
low malignant 
potential
Low grade 
Papillary 
Carcinoma
High grade 
Papillary 
Carcinoma
Architecture
Papillae Delicate Delicate, Occasionally fused.
Fused, branching 
and delicate
Fused, branching 
and delicate
Organization 
of cells
Identical 
to normal
Polarity identical to 
normal; any thickness; 
cohesive
Predominantly 
ordered, yet 
minimal 
crowding and 
minimal loss of 
polarity; any 
thickness; 
cohesive
Predominantly 
disordered with 
frequent loss of 
polarity, any 
thickness; often 
discohesive
Histologic  feature  used  to  classify  Urothelial  Papillary  lesions  according  to  the  scheme  
proposed by  the  WHO/ISUP [The World  Health  Organization /  International  Society  of  
Urological Pathology].19
Cytology
Nuclear 
size
Identical to 
normal
May be uniformly 
enlarged
Enlarged with 
variation in size
Enlarged with 
variation in size
Nuclear 
shape 
Identical to 
normal
Elongated, round-
oval, uniform. 
Round-oval; slight 
variation in shape 
and contour.
Moderate-
marked 
Pleomorphism.
Nuclear 
Chromati
n
Fine Fine
Mild variation 
within and 
between cells.
Moderate-
marked variation 
both within and 
between cells 
with 
hyperchromasia.
Nucleoli Absent Absent to inconspicuous
Usually 
inconspicuous*
Multiple 
Prominent 
nucleoli may be 
present
Mitosos Absent Rare, basal Occasional, at any level
Usually frequent 
at any level
Umbrella 
cells
Uniformly 
present Present Usually present May be absent
*     If present, small and regular and not accompanied by other features of high grade 
     carcinoma. 
  
Pathologic T (Primary tumor) staging of bladder carcinoma18.
                    AJCC/UICC Depth of invasion
Non invasive, Papillary Ta
Carcinoma in situ(Non invasive, flat) Tis
Lamina Propria invasion T1
Muscularis Propria invasion T2
Microscopic extravesicle invasion T3a
Grass apparent extravesicle invasion T3b
Invades adjacent structures T4
Local spread and metastasis
     Bladder carcinoma may extend into the ureters, neck of the bladder, urethra, prostatic ducts  
and seminal vesicle.
     Lymphnode metastasis in the pelvic chains are found in 25% of invasive tumors. The most 
common sites of distant metastatis are the lungs, liver, bone and central  nervous system.
Histochemical and Immunohistochemical features.
     The  co-ordinate  expression  of  CK7  and  CK20  is  a  feature  of  transitional  cell  
carcinoma.CK20 positivity is common and strong in the high grade tumors. Thrombomodulin 
and Uroplakin III are two new useful markers for transitional cell carcinomia, but the former is 
not very specific and the later is only moderately sensitive.
     Other markers commonly expressed by these tumors are CEA and cathepsin B (high grade 
tumors), CA19-9, CD15 (leu M1), survivin and androgen receptors.  Deletion of ABO blood 
group antigen is a common finding in transitional cell carcinomas particularly in high grade 
tumors.  
Staining for the basal lamina component laminin has been advocated for the detection of 
early  stromal  invasion.   Tenascin  an  extra-cellular  matrix  protein  is  strongly  expressed  in 
invasive,  high-grade  carcinomas  with  abundant  stroma  and  is  thought  to  reflect  both  the 
severity of the inflammatory infiltrate and the extent of stromal remodeling
MATERIALS AND METHODS
The present study was undertaken in the Department of Urology in co-ordination with 
Institute  of  Pathology  and  Electron  Microscopy,  Madras  Medical  College,  Govt.  General 
Hospital, Chennai.
From November 2004 to Feb 2007, voided urine specimens were obtained from 52 men 
and 2 women patients, who had symptoms suggestive of bladder tumor. Those with  hematuria 
due to other causes like other bladder tumors, RCC, Upper tract TCC, calculus, infection were 
ruled out from the study.
Voided  urine  specimens  were  collected  from  54  patients  and  subsequently  bladder 
biopsy specimens were obtained from these patients and results were correlated. 
     For cytological examination freshly voided urine was collected in clean container avoiding 
early morning urine.  In case of female patients care was taken to avoid vaginal contamination. 
Urine examination was repeated thrice.  For the purposes of this study, the higher degree of 
abnormality observed in the three specimens was recorded as the conclusive diagnosis.
     Urine specimen was centrifuged 2500 rpm for 20 minutes.  The supernatant was poured into 
disinfectant.  The  cells  in  ‘cellbutton’  mixed  with  the  remaining  one  or  two  drops  of 
supernatant, remaining in the side of the tube by gently flicking the tube with a finger.
     The resulting cell suspension was removed using a pipette.  A single small drop was placed 
towards one end of a clean, labeled glass slide.  It was spread rapidly and the smears are fixed  
in 95% Isopropyl alcohol immediately.
     The slides were fixed at least for a minimum of 20 minutes.  Fixed smears were stained by  
using H & E stain and papanicoloau stain.
     After staining the slides were mounted using DPX [Distrene Dibutylphthalate Xlol].
For Histopathology
     The material was obtained from TURBT Specimen, Cystoscopic biopsy specimen and 
Radical cystectomy specimen.
     The samples received were fixed in 10% formalin of quantity 20 times, the volume of the 
specimen.  Then processed in automated tissue processor with a conventional timing.  Then 
slides were stained using H &E [Haematoxylin and Eosin] stain.
Papanicoloau staining 5
Staining Technique
1. Fix smears (while still moist) in equal parts of alcohol and ether for 15 - 30 minutes.
2. Rinse smears in distilled water.
3. Stain in Harri’s Haematoxylin for 4 mts.
4. Wash in tap water for1-2mts.
5. Differentiate in acid alcohol.
6. Blue in tap water or 1.5%sodium bicarbonate
7. Rinse in distilled water.
8. Transfer to70% then 95% alcohol for few seconds.
9. Stain in OG-6 for 1-2 mts
10. Rinse in 3 changes of 95% alcohol for few seconds each.
11. Stain in EA-36 for 1 - 2 mts
12. Rinse in 3 changes of 95% alcohol for few seconds each
13. Dehydrate  in  absolute  alcohol,  clear  in  xyol  and  mount  in  DPX.[Distrene 
Dibutylphthalate Xlol]
Result
     Nuclei - Blue
     Acidophilic cells - Red to Orange
     Basophilic cells - Green to blue green
     Cells or fragments of tissue penetrated by blood- Orange to Orange Green. 
H & E staining [Heamatoxylin and Eosin] for tissue sections26 
Staining technique
1. Dewax sections, hydrate, through graded alcohol to water
2. Remove fixation pigments if necessary.
3. Stain in alum hematoxylin of choice for a suitable time.
4. Wash well in running tap water until sections ‘blue’ for 5 minutes or less.
5. Differentiate in 1% acid alcohol (1% Hcl in 70% alcohol) for 5- 10 sec
6. Wash well in tap water until sections are again blue (10 - 15 minutes) or
7. Blue by dipping in an alkaline solution (eg ammonia water) followed by a 5 min tap 
water wash.
8. Stain in 1% eosin  for 10 minutes
9. Wash in running tap water for 1 - 5 minutes
10. Dehydrate through alcohols, clear and mount.
Results
     Nuclei - blue/black
     Cytoplasm - varying shades of pink
     Muscle fibres - Deep pink/red
     RBC[Red  blood Cells] -Orange/red
     Fibrin - deep pink
For heamatoxylin and eosin staining of cytology smears 0.5% acid alcohol is used
 for differentiation
Urine cytology smears were diagnosed as
         Negative for malignancy
         Atypical/reactive cells
         Degenerated cells
         Suspicious for malignancy.
         Positive for Malignancy     
                   Low grade
                   High grade
For this purpose of study cytological negative, atypical/ reactive and degenerated smears are 
combined  into  one  group  i.e.  cytologic  negative.  Suspicious  and  positive  smears  were 
combined into another group i.e. cytologic positive.
Histopathology slides were diagnosed as
     No malignancy
     Low grade transitional cell carcinoma
     High grade transitional cell carcinoma
Then Cyto - Histological correlation was done.
Correlation  was  also  done  with  cystoscopic  findings  and  cytological,  histopathalogical 
findings. Histological diagnosis was based on WHO grading
     The tumors showing delicate orderly arranged papillary structures with minimal crowding, 
with enlarged cells, round to oval slightly variable sized nuclei, inconspicuous nucleoli and 
occasionally found mitosis were classified as low grade transitional cell carcinoma
     The tumors showing disorderly arranged papillary structures with loss of polarity, enlarged 
cells with pleomorphic nuclei showing multiple prominent nucleoli and frequent mitosis were 
diagnosed as high grade transitional cell carcinoma.    
Criteria for cytological diagnosis
Atypical/reactive cells
 Enlarged  cells  with  vacuolated  cytoplasm and  large  centrally  placed  nuclei  with  smooth 
nuclear borders and multiple prominent nucleoli and fine even chromatin were diagnosed as 
atypical/reactive cells50,51 
Degenerated cells
     Cells with disintegrated cytoplasm, smudged or degenerated chromatin and degenerated 
nuclei were diagnosed as degenerated cells37.
Suspicious cells
      The diagnosis of suspicious was rendered when the evidence was judged to be strongly  
suggestive of cancer but insufficient for an outright- diagnosis24.
Low-grade transitional cell carcinoma                                                            
      Papillary or loose clusters of large cells with homogeneous cytoplasm and eccentricity 
placed enlarged nuclei with irregular nuclear borders, fine even chromatin were diagnosed as 
low grade transitional cell carcinoma50,51.
Urine sediment smear showing degenerated cell groups showing vacuolated cytoplasm and 
degenerated nuclei. H&E stain 400X.
Urine sediment smear of low grade TCC. Pap stain 400X.
Urine sediment smear of low grade TCC H&E 400X
Histology of low grade papillary TCC showing branching, delicate papillae. Scanner 
view
Histology of low grade papillary TCC showing branching, delicate papillae with 
orderly arrangement of cells H & E 100X.
Histology of low grade papillary TCC showing papillary structure with orderly arranged cells. 
The cells show mild nuclear size variation                          H & E 400X.
    Histology of high grade papillary TCC H &E 100X.
Histology of high grade papillary TCC showing cells with pleomorphic hyperchromatic 
nuclei H & E 400X
Histology of TCC with muscle invasion H & E  100X
Histology of TCC with muscle invasion H& E 400X
High-grade transitional cell carcinoma
      Loose  clusters  or  isolated  large  cells  with  vacuolated cytoplasm,  eccentricity  placed 
pleomeorphic nuclei with increased N/C ratio [Nuclear Cytoplasmic ratio],  irregular nuclear 
borders,  coarse  uneven  chromatin  and  multiple  nucleoli  were  diagnosed  as  high  grade 
transitional cell carcinoma50,51.
      Cyto-hystological correlation was done patient based rather than specimen based.  Such that 
one patient with multiple specimens, correlation was tabulated only one time.
     A positive correlation satisfied one of the two conditions.         
1. A  patient  with  at  least  one  positive  urinary  cytology  concurrent  with  positive 
histological specimen or
2. A patient with consistently negative urinary cytology and histology specimen.
A discordant correlation was taken when at least one positive diagnosis by either cytology or 
histology and negative findings by the other modality.     
An explanation of discordant results was determined. 
RESULTS AND OBSERVATION
 
  A total of 54 cases were studied for cyto-histological correlation of bladder cancer.
    
 Table 1 shows age/sex wise distribution of 54 cases
TABLE 1:
AGE[Years] MALE[Number] FEMALE[Number]
30-39 3
40-49 7 1
50-59 19 1
60-69 18
70-79 4
80-89 1
TOTAL 52 2
Among the study group the most common age group involved is 50- 69 years (68%).
Only 2 patients were females.
   Table 2 shows age/sex wise distribution of histologically proven cases.
                                                     
   TABLE- 2
AGE[Years] MALE[Number] FEMALE[Number]
30-39 3
40-49 7 1
50-59 15
60-69 14
70-79 4
80-89 1
TOTAL 44 1
Among 54 cases, histologically proven bladder tumor cases were 45. 
This group also had the maximum number of patients in the age group of 50 – 69 yrs.
Table  3 shows  cytological  and  cystoscopic  findings  in  histologically  negative  cases 
TABLE 3
CASE 
NUMBE
R
HISTOLOGY CYTOLOGY CYSTOSCOPY
3 Negative Negative Irregular mucosa- lt. lateral wall
21 Negative Negative ? Growth right lateral wall of bladder.
22 Negative. Negative ?Growth right lateral wall
24 Negative Positive No growth
28 Negative Negative Bullous edema - dome
36 Negative Positive No growth
38 Negative Positive No growth
40 Negative Positive No growth
50 Negative Negative Bullous edema - trigone
Histologic diagnosis and cytological findings of 54 cases is shown in Table 4.
TABLE 4:
HISTOLOGY
                 CYTOLOGY
TOTAL
POSITIVE NEGATIVE
LOW  GRADE 11 10 21
HIGH GRADE 19 5 24
NEGATIVE 4 5 9
TOTAL 34 20 54
P - 0.081
Cyto-Histological grading of urothelial neoplasm was shown in TABLE 5
TABLE 5:
HISTOLOGY NUMBER OF CASES
CYTOLOGY
LOW-GRADE HIGH-GRADE
LOW-GRADE 11 10 1
HIGH-GRADE 19 3 16
P < 0.001
Cyto-Histological correlation for patients with bladder cancer shown in 
TABLE 6.
TABLE 6:
HISTOLOGIC
AL GRADE
TOTAL 
NUMBER 
OF CASES
CYTOLOGY % OF 
POSITIVEPOSITIVE NEGATIVE
LOW GRADE 21 11 10 52.38
HIGH GRADE 24 19 5 79.16
 
False positive findings on cytologic examination with clinical findings shown in TABLE 7. 
TABLE 7:
CASE 
NUMBER
CYTOLOGY CLINICAL FINDINGS
24 Positive-low grade Cystoscopy negative.random biopsy negative.
36 Positive -High grade Cystoscopy negative.random biopsy negative. History of radiation present.
38 Positive-High grade Cystoscopy negative.random biopsy negative
40 Positive-low grade Cystoscopy negative.random biopsy negative.
Overall, Cyto-Histological correlation was 65%
52% of the low-grade tumors were detected by cytology.
79% of the high-grade tumors were detected by cytology
Among the 54 cases 
True positives [TP] were 30
False positives [FP] were 4
False  negatives [FN] were 15
True negatives[TN] were 5
TABLE  8 shows these details.
TABLE 8
BIOPSY
TOTAL
CYTOLOGY POSITIVE NEGATIVE
POSITIVE 30[TP] 4[FP] 34
NEGATIVE 15[FN] 5[TN] 20
TOTAL 45 9 54
Specificity of urine cytology= TN/TN+FP=56%
Sensitivity of urine cytology=TP/TP+FN=67%
Positive predictive value of urine cytology = TP/TP+FP=85%
Negative predictive value of urine cytology=TN/TN+FN=25%
     Among the 54 cases 45 were confirmed histologically, which includes 21 cases of low grade  
transitional cell carcinoma and 24 cases of high grade transitional cell carcinoma.
     Among the 54 cases 9 were histologically negative.
      28 out of 45 cases of transitional cell carcinoma were correctly identified by cytological 
examination.
     2 cases showed suspicious cytology.
     15 cases produced negative cytological findings.
     Among the cytologically negative 15 cases, 10 were diagnosed as low grade tumors in  
histology.
     A summary of the cyto-histological grading results are shown in table 5.  High grade TCC 
had high correlation whereas low grade TCC  had a poor correlation.
     Histologically confirmed high grade TCC occurred in 24 patients of whom 19 were detected 
cytologically i.e. 79% were detected by cytology.
     Histologically confirmed low grade TCC occurred in 21 patients of whom 11 were detected 
cytologically i.e. 52% were detected by cytology.
     Histologically confirmed TCC occurred in 45 patients of whom 30 patients were diagnosed 
cytologically i.e. 67% were detected by cytology.  
Assessment of false positive cases:
     Table  9  shows false  positive  cases  i.e.  positive  cytology and negative  histopathology 
diagnosis.
     4 cases showed false positive cytological findings.
     1 out of 4 cases received radiotherapy in the past and the radiation induced changes were 
falsely diagnosed as high grade TCC.  In 3 cases, the cytology was positive and cystoscopy 
showed no growth.in random biopsy was negative for transitional cell carcinoma.IVU & URS 
normal study Thereafter these 3 patients could not be followed up.
Assessment of false negative cases:
     15 cases showed false negative cytology i.e. cytology negative and histology positive.
     Among the 15 cases 10 cases were diagnosed as low grade tumor by histology and 5 were 
diagnosed as high grade tumor by histology.
     Among the 10 low grade tumors, which were cytologically negative, 4 showed atypical and 
degenerative changes and 6 showed only normal urothelial cells.
Urine sediment smear; catheter artifact- showing papillary clusters of cells with 
smooth outline H&E  
 Among the 5 high grade tumors, which were cytologically negative, 3 showed 
atypical changes. Among these 3 which showed atypical changes, 2 showed
 abundant background acute inflammatory cell collection.
     During our study we came across one urinary specimen smear which showed papillary 
clusters with smooth borders; it was due to previous catheterization.
DISCUSSION
      A cytological  examination  of  voided  urine  is  a  non  invasive  method  of  detection, 
diagnosis and follow up of tumors of the lower urinary tract. Bladder washing or barbotage is 
an invasive procedure.  In  our  study voided urine samples from the patients  were used for 
cytological examination.
     The value of repeated cytological examination of urine for 3 consecutive days was 
reported by Leopold G. Koss et al 198524.  In the present study also urine was examined on 3 
consecutive days.
     The average patient is 65 to 70 years old and most patient are older than 50 years In our 
study maximum number of cases (29) occurred in the age group of  50 - 69 years and total  
number of patients over 50 years of age was 34.
     Consistent with previously published data13,14,24,44 in the literature, this study also showed 
higher diagnostic accuracy with high grade tumors and low with low grade tumors. In our study 
79% high grade tumors were detected by cytology but only 52% of the low grade tumors were 
detected by cytology.
     Cigarette smoking is a risk factor for bladder cancer. In our study, of the 45
 biopsy proven bladder cancer cases, 39 cases occurred in smokers.
     Eighty percent of the patients with bladder carcinoma present with gross or microscopic 
hematuria21. In our study hematuria is a presenting symptom in 45 out of 45 biopsy proven 
bladder cancer patients.
     Cystoscopy and cytology are complementary studies. The low grade papillary lesions that 
may be difficult to diagnose cytologically are usually easy to diagnose  cystoscopically. In our 
study out of 10 cases which were falsely diagnosed as negative in cytological examination ,8 
showed cystoscopically diagnosable growth.
     The sensitivity and specificity of the voided urine cytology in the studies conducted by 
various authors.
S.NO Author Sensitivity Specificity
1. M.N.EL-Bolkainy30 1980 44.7 to 97.3% 
(73.8%)
88% to 99.5% (97.1%)
2. Uma A. Shenoy et al44 1985 85% 99%
3. Asitava Mondal et al4 1992 92% 88%
4. Misra V et al28 2000 47.37% 41.18%
5. V. Poulakis et al46 2001 62% 96%
6. A. Saad  et al3 2002 48% 87%
7. Planz B et al35 2005 38% 98.3%
    Our study showed a sensitivity of 67% and specificity of 56% for urine cytology.
     The study conducted by William M. Murphy et al50 1984-showed overall cyto-histological 
correlation of 92%
     The study conducted by Uma A. Shenoy et al44 1985-showed overall cyto-histological 
correlation of 74%
     In the study conducted by DiBonito L et al7 1992 cyto-histological correlation varied from 
20% to 92.8%.
     In  our  study  the  overall  cyto-histological  correlation  was  65%. 
False positive cases:
     Radiation can cause cellular changes like multinucleation, nuclear enlargement, cytoplasmic 
vacuolation, Karyorrhexis. 
     The study conducted by P. N. Cowen36 showed that it is impossible to state with any degree 
of certainty whether any atypical or bizarre cells seen in urine indicate a neoplastic origin or 
whether they are due to the irradiation of non-neoplastic epithelial cells.
     Our study also showed similar findings. In one case, who previously received radiation, the 
urine  cytology  showed  bizarre  cells  which  were  diagnosed  falsely  as  high  grade  TCC 
[Transitional cell carcinoma].
     So it is essential that the cytologists be informed whether (and when) previous radiotherapy 
has been given to the patient as insisted by P. N.Cowen36.
     In 3 cases, the cytology was positive and cystoscopy showed no growth. Random biopsy  
was negative for transitional cell carcinoma. Thereafter these 3 Patients could not be followed 
up. . 
     According to David M. Schwalb et al6, inadequate follow up may be the cause of false-
positivity,  he also said that  a  positive  and even suspicious result  in the  absence of visible  
disease  in  the  previously  untreated  patient  predicts  the  eventual  development  of  clinically 
recognizable transitional cell carcinoma, mainly in the bladder.                   
False positive rates reported by various authors:
        The study conducted by M.N.EL-Bolkainy30 showed false positive rate of 1.5%. The study 
conducted by Uma A. Shenoy et al44 showed false positive rate of 11%. According to Edward 
M. Messing8 it was 1-12%.
     In our study it is 12%, it also correlates well with other authors’ study.
     False positive cytological findings may develop a tumor in subsequent years and therefore 
needs repeated examination of urine for malignant cells4,31,44.
False negative cases:
     Among the 45 biopsy proven bladder neoplastic cases 15 were falsely diagnosed as negative 
cytologically.  Among the15 cases 10 were low grade tumor and 5 were high grade tumors.
     Among the 10 low grade tumors, which were cytologically negative 6 showed only normal 
urothelial  cells  and  4  showed  atypical  and  degenerative  changes.  This  may  be   due  to 
exfoliation of non-diagnostic cells from low grade tumors.
     Among the 5 high grade tumors which were cytologically negative, 3 showed atypical 
cellular changes. Among the 3, two showed heavy background inflammatory cell collection. 2 
out of 5 high grade tumors didn’t show any malignant cells in cytology. This may be due to 
masking of the tumor cells by associated inflammation or hemorrhage, and scanty exfoliation 
of necrotic tumors as stated by M.N.EL-Bolkainy30.
     Three case of histologically proven high grade tumors were detected as low grade tumors by  
cytology and one case of histological low grade tumor was cytologically diagnosed as high 
grade tumor, a more likely explanation is that the bladder cancers are rarely composed of a pure 
population of cells, all of which are in the same stage of differentiation at any one point in time.  
High grade TCC may exhibit surface maturation, and tumor cells exfoliated from these areas 
could  have  a  cytological  features  of  a  low-grade neoplasm,  less  commonly  small  areas  of 
anaplasia may exist within predominantly low grade tumors.
LIMITATIONS
 As the sample population is small the sensitivity and specificity of this study may not be so 
accurate.
 False positive cases could not  be evaluated with flexible URS as it is not available.
 False positive cases were lost to subsequent follow up, hence their ultimate fate could not 
be elucidated. 
SUMMARY
 More than 60% (64.44 %) of cases occurred in the age group of 50 -69  years, with 
male preponderance
 Around 2/3 (67%) of the bladder cancers can be detected by simple, non-invasive, 
voided urine cytology.
 Nearly 80% (79%) of the high grade bladder cancers can be detected by voided urine 
cytology.
 Only half (52%) of the low grade bladder cancers can be detected by voided urine 
cytology.
 More  than  60%  (65%)  of  the  cytological  diagnosis  correlated  well  with 
histopathological diagnosis.
 Cytological grading correlated with histopathological grading in more than 80% of 
cases. 
 Inadequate follow up and previous therapy led to false positive diagnosis.
 Cystoscopy is  more useful  in  low grade tumors which were diagnosed falsely as 
negative by cytology.
CONCLUSION
 Cytological examination of urine specimen is valuable as an aid in the diagnosis  of 
bladder tumors.
 Voided urine cytology correlates  with histological diagnosis in more than 60% of cases.
 The accuracy is more with high grade tumors 
 Urine cytology grading correlates in most cases with histopathological grading.
 The  voided  urine  cytology  is  not  only  of  diagnostic,  but  also  of  prognostic  value; 
positive cytology of high grade presumably identifies patients at high risk for high grade 
and invasive tumours.
 Cystoscopy is essential in diagnosing low grade tumors which were mostly missed by 
voided urine cytology.
 Voided  urine  cytological  study  can  be  a   valuable  adjunct  to  the  clinician  in  the 
evaluation of suspected urothelial malignancy, as it  is simple, non-invasive and with 
good accuracy in the diagnosis of TCC. 
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                                       PROFORMA
COMPARISON OF URINARY CYTOLOGY WITH 
HISTOPATHOLOGICAL EXAMINATION IN BLADDER 
TRANSITIONAL CELL CARCINOMA
        NAME:
         IP NO:
        OCCUPATION:
         CLINICAL PRESENTATION:
         SMOKING HISTORY:
          PREVIOUS HISTORY OF ANY UROTHELIAL MALIGNANCY:
          CLINICAL EXAMINATION:
          INVESTIGATION:
         URINE ROUTINE
         URINE C/S
         USG KUB
          IVU
         CYSTOSCOPY
         URINE CYTOLOGY:
         C. NO:
         CYTOLOGY REPORT
          PROCEDURE:
        
 
             
             HISTOPATHOLOGICAL EXAMINATION:
             B. NO:
             HPE REPORT:
Master Chart
Case 
No Age/Sex IP.No
Cytological Diagnosis Histopathological Diagnosis
C.No
Positive
Negative Suspicious B.No
Positive
NegativeGrade Grade
Low High Low High
1 36/M 684210/04 5109/04 * 5761/04 *
2 46/M 685552/04 5341/04 * 6424/04 *
3. 55/M 684773/04 5407/05 * 6152/05 *
4. 45/M 684745/04 5408/05 * 6060/05 *
5. 57/M 685395/04 5492/05 * 6151/05 *
6. 65/M 689193/04 6042/05 * 6693/05 *
7. 50/M 696753/04 6571/05 * 7282/05 *
8. 69/M 700618/05 1/05 * 186/05 *
9 72/M 704264/05 471/05 * 482/05 *
10. 50/M 707349/05 834/05 * 955/05 *
11. 46/M 708362/05 929/05 * 934/05 *
12. 61/M 708453/05 946/05 * 1014/05 *
13. 55/M 709585/05 1024/05 * 961/05 *
14. 44/M 710411/05 1142/05 * 1128/05 *
15 65/M 704270/05 1226/05 * 1035/05 *
16 63/M 710102/05 1376/05 * 933/05 *
17 60/M 712379/05 1411/05 * 2080/05 *
18 50/M 712348/05 1412/05 * 1671/05 *
19 45/M 713183/05 1421/05 * 1558/05 *
20 47/M 710084/05 1438/05 * 1327/05 *
21 50/F 714274/05 1506/05 * 1223/05 *
22 68/M 714423/05 1629/05 * 1490/05 *
23 70/M 716892/05 1883/05 * 1602/05 *
24 68/M 716878/05 1895/05 * 1815/05 *
25 60/M 717720/05 2038/05 * 1763/05 *
26 59/M 715917/05 2976/05 * 1628/05 *
27 65/M 718966/05 2165/05 * 1963/05 *
28 59/M 720086/05 2166/05 * 1967/05 *
29 52/M 720549/05 2406/05 * 2101/05 *
30 64/M 724401/05 3044/05 * 2723/05 *
Case 
No Age/Sex IP.No
Cytological Diagnosis Histopathological Diagnosis
C.No
Positive
Negative Suspicious B.No
Positive
NegativeGrade Grade
Low High Low High
31 65/M 726712/05 3099/05 * 2719/05 *
32 55/M 724603/05 3128/05 * 2741/05 *
33 49/M 639747/05 3944/06 * 2989/06 *
34 65/M 732583/05 4061/06 * 4129/06 *
35 54/M 734048/05 4064/06 * 3619/06 *
36 51/F 750184/05 4075/06 * 5041/06 *
37 65/M 753638/05 4083/06 * 5140/06 *
38 55/M 733837/05 4085/06 * 5970/06 *
39 85/M 734863/05 4195/06 * 3620/06 *
40 60/M 736076/05 4199/06 * 3914/06 *
41 65/M 737702/05 4440/06 * 4206/06 *
42 38/M 743201/05 4717/06 * 3802/06 *
43 50/M 743538/05 4985/06 * 4727/06 *
44 60/M 745407/05 5185/07 * 4542/07 *
45 58/M 745207/05 5251/07 * 4436/07 *
46 40/F 752349/05 5973/07 * 5068/07 *
47 51/M 753042/05 6212/07 * 5454/07 *
48 70/M 754780/05 6331/07 * 5479/07 *
49 52/M 755680/05 6469/07 * 5481/07 *
50 52/M 765278/05 6853/07 * 6088/07 *
51 69/M 764855/05 7397/07 * 6254/07 *
52 50/M 770398/05 8000/07 * 6748/07 *
53 70/M 773171/05 8336/07 * 290/07 *
54 36/M 782218/06 738/07 * 777/07 *
